{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:45:40Z","timestamp":1788867940046,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.vaccine.2020.01.037","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T13:55:59Z","timestamp":1579874159000},"page":"2198-2201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Live attenuated MMR\/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: Multicenter, retrospective data collection"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4655-1652","authenticated-orcid":false,"given":"Yosef","family":"Uziel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Moshe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Onozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kulcs\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di\u00e1na","family":"Tr\u00f3bert-Sipos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Akikusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gecilmara","family":"Salviato Pileggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despoina","family":"Maritsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1125-7720","authenticated-orcid":false,"given":"Ozgur","family":"Kasapcopur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roubini","family":"Smerla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Rigante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balahan","family":"Makay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erato","family":"Atsali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Wulffraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4696-1646","authenticated-orcid":false,"given":"Nata\u0161a","family":"Toplak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.vaccine.2020.01.037_b0005","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.10524","article-title":"Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study","volume":"46","author":"Doran","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2020.01.037_b0010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/berh.2001.0226","article-title":"Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis","volume":"16","author":"Fessler","year":"2002","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2020.01.037_b0015","article-title":"Serious\/at least moderate infections in patients with juvenile idiopathic arthritis on synthetic and biologic drugs from the pharmachild registry [abstract]","volume":"2019","author":"Giancane","year":"201978","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2020.01.037_b0020","article-title":"An international survey on approaches towards immunisation in children with rheumatic diseases: a report of the PRES Vaccinations Working Group [abstract]","volume":"78","author":"Moraitis","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2020.01.037_b0025","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/ard.2011.150193","article-title":"EULAR recommendations for vaccination in paediatric patients with rheumatic diseases","volume":"70","author":"Heijstek","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2020.01.037_b0030","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11926-015-0519-y","article-title":"Vaccinations in paediatric rheumatology: an update on current developments","volume":"17","author":"Groot","year":"2015","journal-title":"Curr Rheumatol Rep"},{"issue":"23","key":"10.1016\/j.vaccine.2020.01.037_b0035","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1001\/jama.2013.6768","article-title":"Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial","volume":"309","author":"Heijstek","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2020.01.037_b0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12969-018-0235-z","article-title":"The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey","volume":"1;16(1)","author":"Jeyaratnam","year":"2018","journal-title":"Pediatr Rheumatol Online J."},{"key":"10.1016\/j.vaccine.2020.01.037_b0045","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/emermed-2019-208490","article-title":"Could this be measles?","volume":"36","author":"O'Donnell","year":"2019","journal-title":"Emerg Med J"},{"key":"10.1016\/j.vaccine.2020.01.037_b0050","unstructured":"Vaccination Working Group of the Pediatric Rheumatology Society of Europe (https:\/\/www.pres.eu\/committee-and-wp\/working-parties.html)."},{"key":"10.1016\/j.vaccine.2020.01.037_b0055","unstructured":"World Health Organization. The global vaccine action plan, 2001-2020, Annex 6: The monitoring and evaluation\/accountability framework. Geneva: World Health Organization, 2013. (https:\/\/www.who.int\/immunization\/global_vaccine_action_plan\/GVAP_Annex6.pdf) Accessed 7 December 2019."},{"key":"10.1016\/j.vaccine.2020.01.037_b0060","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1136\/ard.2006.063586","article-title":"Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis","volume":"66","author":"Heijstek","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2020.01.037_b0065","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/annrheumdis-2011-200637","article-title":"Differences in persistence of measles, mumps, rubella, diphteria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study","volume":"71","author":"Heijstek","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2020.01.037_b0070","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/rheumatology\/ken436","article-title":"Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept","volume":"48","author":"Borte","year":"2009","journal-title":"Rheumatol (Oxford, England)."},{"key":"10.1016\/j.vaccine.2020.01.037_b0075","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1016\/j.vaccine.2015.06.086","article-title":"Long-term safety and efficacy of varicella vaccination in children with juvenile idiopathic arthritis treated with biologic therapy","volume":"33","author":"Toplak","year":"2015","journal-title":"Vaccine"},{"issue":"35","key":"10.1016\/j.vaccine.2020.01.037_b0080","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1016\/j.vaccine.2017.04.015","article-title":"Varicella vaccination elicits a humoral and cellular response in children with rheumatic diseases using immune suppressive treatment","volume":"15","author":"Groot","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.037_b0085","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/acr.20183","article-title":"Safety and immunogenicity of varicella vaccine in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids","volume":"62","author":"Pileggi","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.vaccine.2020.01.037_b0090","unstructured":"Wulffraat NM, de Groot AM, Nieuwenhuis EES. Vaccination in children and adolescents with rheumatic conditions. Editorial. Medicine Matters--Rheumatology 2018; 18 October. https:\/\/rheumatology.medicinematters.com\/infection\/vaccination\/vaccination-in-children-andadolescents with-rheumatic-condition\/16208342. Accessed 1 September 2019."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20300529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20300529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:40:52Z","timestamp":1759401652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20300529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0264410X20300529"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.01.037","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Live attenuated MMR\/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: Multicenter, retrospective data collection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.01.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}